Physician profile
Palvi Patel
NPI 1578705620
$2,366.95
in general payments reported to CMS, 2019-2025
25 companies · $24.94 in 2025
The $24.94 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,037 · 2020: $185 · 2021: $23.68 · 2022: $421 · 2023: $559 · 2024: $117 · 2025: $24.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $464.31 | 2019-2023 | Camzyos |
| Inari Medical, INC. | $319.39 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.80 | 2019-2024 | Jardiance |
| Portola Pharmaceuticals, LLC | $167.82 | 2019 | |
| Ucb, INC. | $156.28 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $132.66 | 2019-2021 | |
| Boston Scientific Corporation | $127.19 | 2023 | Watchman Access System |
| Chiesi USA, INC. | $91.71 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $83.92 | 2019 | |
| Merck Sharp & Dohme LLC | $83.41 | 2019-2022 | |
| Abiomed | $82.21 | 2022 | |
| Astellas Pharma US INC | $71.77 | 2020-2022 | |
| La Jolla Pharmaceutical Company | $61.01 | 2019-2020 | |
| Mylan Specialty L.P. | $45.62 | 2022 | |
| Genzyme Corporation | $34.19 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $29.09 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $27.06 | 2019-2020 | |
| Abbott Laboratories | $24.94 | 2025 | Freestyle Libre 3 |
| Mallinckrodt Hospital Products INC. | $22.32 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $21.02 | 2019 | |
| Paratek Pharmaceuticals, INC. | $18.91 | 2020 | |
| Novartis Pharmaceuticals Corporation | $18.43 | 2022 | |
| Cook Medical LLC | $16.26 | 2019 | |
| Insmed, INC. | $15.82 | 2019 | |
| Pfizer INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Palvi Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.